Clinical Trial Update: Efficacy of Fish Oil in Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results evaluate the efficacy of fish oil as an adjunct in relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Fish oil

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Relapsing- Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED